Heparin-induced thrombocytopenia;Heparin-induzierte thrombozytopenie - Pathophysiologie, klinik, therapie, prophylaxe

Intensivmedizin und Notfallmedizin

Volumn 35, Issue 5, 1998, Pages 307-315

  Laubenthal, F C A ^a   Sabin, G V ^a  

^a ELISABETH KRANKENHAUS ESSEN   (Germany)

Author keywords

Diagnostic tests; HIT type I and II; Prophylaxis; Recombinant hirudin; Thromboembolic complications

Indexed keywords

ABCIXIMAB; ANTICOAGULANT AGENT; ANTITHROMBIN III; ARGATROBAN; DANAPAROID; DICOUMAROL; HEPARIN; LEPIRUDIN; PHENPROCOUMON; PROTHROMBIN; THROMBOCYTE FACTOR 4;

ANTICOAGULATION; COMPLEX FORMATION; DRUG INDUCED DISEASE; ENDOTHELIUM INJURY; HEART INFARCTION; HUMAN; INCIDENCE; LIMB AMPUTATION; MORTALITY; ORAL DRUG ADMINISTRATION; PARTIAL THROMBOPLASTIN TIME; REVIEW; STROKE; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA; THROMBOEMBOLISM;

EID: 0031849221     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003900050153     Document Type: Review

References (56)

1. Amiral J, Bridey F, Dreyfus M. Vissac AM, Fressinaud E, Wolf M, Meyer (1992) Platelet factor 4 complex to heparin is target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 68: 95-96
2. Amiral J, Bridey F, Wolf M, Boyer-Neumann C, Fressinaud E, Vissac AM, Peynaud-Debayle E, Dreyfus M, Meyer D (1995) Antibodies to macromolecular platelet factor 4. Heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb Haemost 73: 21-28
3. Astor RH (1995) Heparin-induced thrombocytopenia and thrombosis. N Engl J Med 332: 1374-1376
4. Barradas MA, Mikhailidis DP, Epemolu O, Jeremy JY, Fonseca V, Dandona P (1987) Comparison of the platelet pro-aggregatory effect of conventional unfractionated heparins and low molecular weight heparin fraction (CY 222). Br J Haematol 67: 451-457
5. Bux-Gewehr I, Helmling E. Seyfert UT (1996) Hyperkoagulabilität infolge Heparin-assoziierter Thrombozytopenie Typ II. Z Kardiol 85: 656-660
6. Chong BH, Burgess J, Ismail F (1993) The clinical usefulness of the platelet aggregation test for diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 69: 344-350
7. Chong BH, Ismail F, Cade J, Gallus AS, Gordon S, Chesterman CN (1989) Heparin-induced thrombocytopenia a: studies with a new low molecular weisht heparinoid, Org 10172. Blood 73: 1592-1596
8. Chong BH, Ismail F, Chesterman CN, Berndt MC (1989) Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets. Br J Haematol 73: 235-240
9. Chong BH, Pilgrim RL, Cooley MA, Chesterman CN (1993) Increased expression of platelet IgG Fc receptors in immune heparin-induced thrombocytopenia. Blood 81: 988-993
10. Chong BH, Pitney WR, Castaldi PA (1982) Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis and platelet aggregation. Lancet 1246-1249
11. Cines DB, Tomski A, Tannabaum S (1987) Immune endothelial-cell injury in heparin-associated thrombocytopenia. N Engl J Med 316: 581-589
12. Demers C, Ginsberg JS, Brill-Edwards P, Panju A, Warketin TE, Anderson DR, Turner C, Kelton JG (1991) Rapid anticoagulation using Ancrod for heparin-induced thrombocytopenia. Blood 78: 2194-2197
13. Eichinger S, Kyrle P, Breuner B, Wagner B, Kapiotis S, Lechner K, Kroninger HC (1991) Thrombozytopenia associated with low-molecular-weight heparin. Lancet 337: 1425-1426
14. Eichler P, Greinacher A (1996) Anti-hirudin antibodies by recombinant hirudin in the treatment of patients with heparin-induced thrombocytopenia (HIT). Ann Hematol abstract 72
15. Emig U, Meyer T, Buchwald AB (1997) Erfolgreiche Lysetherapie einer Vena-cava-inferior- und Iliofemoral-Venenthrombose bei Heparin-induzierter Thrombozytopenie Typ II. Dtsch med Wschr 122: 965-968
16. Greinacher A (1995) Antigen generation in heparin-associated thrombocytopenia: the nonimmunologic type and the immunologic type are closely linked in their pathogenesis. Semin Thromb Hemost 21: 106-116
17. Greinacher A (1996) Heparin-induzierte Thrombozytopenie. internist 37: 1172-1178
18. Greinacher A, Alban S, Dummel V, Franz G, Mueller-Eckhardt C (1995) Characterization of the structural requirements for a carbonhydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin, induced thrombocytopenia. Thromb Haemost 74: 886-892
19. Greinacher A, Amiral J, Dummel V, Vissac A, Kiefel V, Mueller-Eckhardt C (1994) Laboratory diagnosis of heparin associated thrombozytopenia and comparison of platelet aggregation test, heparin-induced activation test, and platelet factor 4/heparin enzym-linked immunosorbent assay. Transfusion 34: 381-385
20. Greinacher A, Eichler P (1995) Die Heparin-assoziierte Thrombozytopenie-Klinik. Labordiagnostik, Pathophysiologie und Therapie. DG Klinische Chemie Mitteilungen 5: 26
21. Greinacher A, Michels I, Mueller-Eckhardt C (1992) Heparin associated Thrombocytopenia: The antibody is not heparin specific. Thromb Haemost 67: 545-549
22. Greinacher A, Michels I, Kiefel V, Mueller-Eckhardt C (1991) A rapid and sensitive test for diagnosing heparin-associated thrombozytopenia. Thromb Haemost 66: 734-736
23. Greinacher A, Mueller-Eckhardt C (1991) Diagnostik der Heparin-assoziierten Thrombozytopenie. Dtsch med Wschr 116: 1479-1482
24. Greinacher A, Mueller-Eckhardt C (1991) Therapie der Heparin-assoziierten Thrombozytopenie. Dtsch med Wschr 116: 1483-1484
25. Greinacher A, Pötzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C (1994) Heparin-associated thrombocytopenia: Isolation of the antibody and characterisation of a multimolecular PF 4-heparin complex as the major antigen. Thromb Haemost 71: 247-251
26. Greinacher A, Völpel H, Pötzsch B (1996) Recombinant hirudin in the treatment of patients with heparin-associated thrombocytopenia. Ann Hematol abstract (72)
27. Hach-Wunderle V, Belova J, Greinacher A, Nestle HW (1997) Use of recombinant hirudin as an anticoagulant during arterial surgery in two patients with relative thrombocytopenia. Ann Hematol abstract (74) Suppl II
28. Hach-Wunderle V, Kainer K, Krug B, Mueller-Berghaus G, Poetzsch B (1994) Heparin-associated thrombosis despite normal platelet counts. Lancet 344: 469-470
29. Harenberg J, Huhle G, Piazolo L, Wang LU, Heene DL (1997) Anticoagulation in patients with heparin-induced thrombocytopenia. Semin Thromb Hemost 23: 189-196
30. Horellou MH, Conrad J, Lecrubier C, Samama M, Fenoyl O de, Di Maria G, Bernadou A (1984) Persistent heparin-induced thrombozytopenia despite therapie with low-molecular-weight heparin. Thromb Haemost 51: 134
31. Home III MK, Chao ES (1989) The effect of molecular weight on heparin bindins to platelets. Br J Haematol 74: 306-312
32. Home III MK, Chao ES (1989) Heparin binding to resting and activated platelets. Blood 74: 238-243
33. Jeske W, Walenga JM, Hoppensteadt D, Fabbrini N, Yang L, Szatkowski E, Fareed J (1996) Validity of the laboratory methods for the diagnosis of HIT. Comparative studies on the 14 C-serotonin release, anti heparin/platelet factor 4 antibodies, platelet aggregometry. and flow cytometric methods. Blood 88: 317 (Suppl 1) abstract 1256
34. Kapsch D, Silver D (1981) Heparin-induced thrombocytopenia with thrombosis and hemorrhage. Arch Surg 116: 1423-1427
35. Kelton JG, Sheridan D, Santos A, Smith J, Steeves K, Smith C, Brown C, Murphy WG (1988) Heparin-induced thrombozytopenia: laboratory studies. Blood 72: 925-930
36. Kelton JG, Smith J, Warkentin TE, Hayward CPM, Denomme GA, Horsewood P (1994) Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 83: 3232-3239
37. King DJ, Kelton G (1984) Heparin-associated thrombozytopenia. Ann Intern Med 100: 535-540
38. Kroll H, Günther K, Müller-Eckhardt C (1997) Immunologie studies in 1459 patients with clinical suspected heparin-induced thrombocytopenia. Ann Hematol abstract A 63 (74) Suppl II
39. Lecompte T, Luo SK, Stieltjes N, Lecrubier C, Samama MM (1991) Thrombozytopenia associated with low-molecular-weight heparin. Lancet 338: 1217
40. Lefkovits J, Plow EF, Topol EJ (1995) Platelet glykoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 332: 1553-1559
41. Lewis BE, Walenga JM, Wallis DE (1997) Anticoagulation with Novastan (Argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrom. Semin Thromb Hemost 23: 197-202
42. Lewis E, Rao RC, Robinson JA, Wallis D, Wallenga JM, Fareed J, Donkin J, McKiernan T (1995) Early plasmapheresis reduces mortality in patients with heparin-induced Thrombosis. Blood 919 (abstract) (86 Suppl 1)
43. Magnani HN (1993) Heparin-induced thrombozytopenia (HIT): an overview of 230 patients treated with Orgaran (Org 10172). Thromb Haemost 70: 554-561
44. Markwardt F (1994) The development of hirudin as an antithrombotic drug: Thromb Res 74: 1-23
45. Nurmohamed MT, Berckmans RJ, Morrien-Salomons WM, Berends F, Hommes DW, Rijnierse JJMM, Sturk A (1994) Monitoring anticoagulant therapie by activated partial thromboplastin time: Hirudin assessment. Thromb Haemost 72: 685-692
46. Prull A. Nechwatal R. Mäurer W (1990) Fulminante venöse und arterielle Thrombosen unter Heparintherapie. Dtsch med Wschr 115: 456-459
47. Prull A, Nechwatal R, Riedel H, Mäurer W (1992) Therapie des Heparin-induzierten Thrombose-Thrombozytopenie-Syndroms mit Immunglobulinen. Dtsch med Wschr 117: 1838-1842
48. Röthing HJ, Grötsch H, Luus HG, Meyer BH, Rosenkranz B (1991) Humanpharmakologische Untersuchungen von rekombinantem Hirudin (HBW 023). Haemostaseologie 11: 132-136
49. Salzmann EW, Rosenberg RD, Smith MH, Lindom JN, Favreau L (1980) Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest 65: 64-73
50. Sheridan D, Carter C, Kelton JG (1986) A diagnostic test for heparin-induced thrombocytopenia. Blood 67: 27-30
51. Sobel M, Adelmann B (1988) Characterization of heparins and other glycosaminoglycans. Thromb Res 50: 815-826
52. Visentin GR, Ford SE, Scott JP, Aster RH (1994) Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 93: 81-88
53. Warkentin TE, Kelton JG (1991) Heparin-induced thrombocytopenia. Prog Hemost Thromb 10: 1-34
54. Warkentin TE, Levine M, Hirsh J, Horsewood P, Roberts R, Tech M, Gent M, Kelton JG (1995) Heparin-induced thrombozytopenia in patients with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 332: 1330-1335 (20)
55. Weisman RE, Tobin RW (1958) Arterial embolism occuring during systemic heparin therapie. Arch Surg 76: 219
56. Westphal K, Matheis G, Strouhal U, Lischke V, Martens S, Wimmer-Greinecker G (1997) Heparin-induzierte Thrombozytopenia-Typ II als Komplikation der Heparingabe nach Eingriff bei Aorta-ascendens-Dissektion. Z Herz-, Thorax-, Gefäßchir 11: 121-126